BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cen Q, Gao T, Ren Y, Lu X, Lei H. Immune evaluation of a Saccharomyces cerevisiae-based oral vaccine against Helicobacter pylori in mice. Helicobacter 2021;26:e12772. [PMID: 33219579 DOI: 10.1111/hel.12772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lei H, Li S, Lu X, Ren Y. Oral administration of Saccharomyces cerevisiae displaying VP28-VP24 confers protection against white spot syndrome virus in shrimp. Virus Res 2021;302:198467. [PMID: 34062193 DOI: 10.1016/j.virusres.2021.198467] [Reference Citation Analysis]
2 Sun S, Xu X, Liang L, Wang X, Bai X, Zhu L, He Q, Liang H, Xin X, Wang L, Lou C, Cao X, Chen X, Li B, Wang B, Zhao J. Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota. Front Immunol 2021;12:777665. [PMID: 34899735 DOI: 10.3389/fimmu.2021.777665] [Reference Citation Analysis]
3 Wang S, Ma J, Ji Q, Liu Q. Evaluation of an attenuated Listeria monocytogenes as a vaccine vector to control Helicobacter pylori infection. Immunol Lett 2021;238:68-74. [PMID: 34363896 DOI: 10.1016/j.imlet.2021.07.010] [Reference Citation Analysis]
4 Gao T, Ren Y, Li S, Lu X, Lei H. Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice. Microb Cell Fact 2021;20:95. [PMID: 33952256 DOI: 10.1186/s12934-021-01584-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]